drugset / Trial / NCT00294255

Risperidone Plus Mood Stabilizer in Treatment of Mixed Mania

NCT00294255

NaSingle-groupOpen-labelTreatment

Summary

The study aims to assess the efficacy and tolerability of risperidone added to lithium, valproate or lamotrigine in patients experiencing a manic episode with depressive or irritable features.

Timeline

Start
2003-03
Primary completion
2006-10
Completion
2006-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Risperidone Other / unclassified 1 mg
Subject Risperidone Other / unclassified 3 mg

Indications